Business · 09/10/2020Updated: 10/17/2026 · 1 min read
Wockhardt Ltd., et al.; FDA Withdraws Approval of Nine Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of nine abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications that the drug products were no longer in market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →